Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: Results from the multimodal treatment study of children with ADHD (MTA)

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 54, Issue 1, 2015, Pages 62-70.e3

  Fernández de la Cruz, Lorena ^a   Simonoff, Emily ^a   McGough, James J ^b   Halperin, Jeffrey M ^c   Arnold, L Eugene ^d   Stringaris, Argyris ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Attention deficit hyperactivity disorder; Irritability; Oppositional defiant disorder; Treatment outcomes

Indexed keywords

DEXAMPHETAMINE; IMIPRAMINE; METHYLPHENIDATE; PEMOLINE; ADRENERGIC RECEPTOR AFFECTING AGENT; CENTRAL STIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD; COMMUNITY CARE; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; OPPOSITIONAL DEFIANT DISORDER; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMPLICATION; CONTROLLED STUDY; DRUG EFFECTS; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IRRITABLE MOOD; MALE; TREATMENT OUTCOME;

EID: 84925353257     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2014.10.006     Document Type: Article

References (45)

1. Shaw P, Stringaris A, Nigg J, Leibenluft E. Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry. 2014;171: 276-293
2. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1073-1086
3. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164:942-948
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edition (DSM-5). Washington, DC: American Psychiatric Association; 2013
5. Leibenluft E. Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths. Am J Psychiatry. 2011;168: 129-142
6. Still GF. Some abnormal psychical conditions in children: excerpts from three lectures. J Atten Disord. 2006;10:126-136
7. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997; 121:65-94
8. Stringaris A, Goodman R. Mood lability and psychopathology in youth. Psychol Med. 2009;39:1237-1245
9. Greene RW, Biederman J, Zerwas S, Monuteaux MC, Goring JC, Faraone SV. Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder. Am J Psychiatry. 2002;159:1214-1224
10. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40:147-158
11. Hechtman L, Abikoff H, Klein RG, et al. Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices. J Am Acad Child Adolesc Psychiatry. 2004;43:830-838
12. Daley D, Van der Oord S, Ferrin M, et al. Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains. J Am Acad Child Adolesc Psychiatry. 2014;53:835-847
13. Aebi M, Muller UC, Asherson P, et al. Predictability of oppositional defiant disorder and symptom dimensions in children and adolescents with ADHD combined type. Psychol Med. 2010;40:2089-2100
14. Stringaris A, Goodman R. Longitudinal outcome of youth oppositionality: irritable, headstrong, and hurtful behaviors have distinctive predictions. J Am Acad Child Adolesc Psychiatry. 2009;48:404-412
15. Whelan YM, Stringaris A, Maughan B, Barker ED. Developmental continuity of oppositional defiant disorder subdimensions at ages 8, 10, and 13 years and their distinct psychiatric outcomes at age 16 years. J Am Acad Child Adolesc Psychiatry. 2013;52:961-969
16. Stringaris A, Goodman R. Three dimensions of oppositionality in youth. J Child Psychol Psychiatry. 2009;50:216-223
17. Stringaris A, Zavos H, Leibenluft E, Maughan B, Eley TC. Adolescent irritability: phenotypic associations and genetic links with depressed mood. Am J Psychiatry. 2012;169:47-54
18. Ahmann PA, Waltonen SJ, Olson KA, Theye FW, Van Erem AJ, LaPlant RJ. Placebo-controlled evaluation of Ritalin side effects. Pediatrics. 1993;91:1101-1106
19. Childress AC, Arnold V, Adeyi B, et al. The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial. J Atten Disord. 2014;18: 123-132
20. Coghill D. Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes. Evid Based Ment Health. 2007; 10:124
21. Manos MJ, Brams M, Childress AC, Findling RL, Lopez FA, Jensen PS. Changes in emotions related to medication used to treat ADHD. Part I: literature review. J Atten Disord. 2011;15:101-112
22. Mongia M, Hechtman L. Cognitive behavior therapy for adults with attention-deficit/hyperactivity disorder: a review of recent randomized controlled trials. Curr Psychiatry Rep. 2012;14:561-567
23. Sonuga-Barke EJ, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170:275-289
24. Galanter CA, Carlson GA, Jensen PS, et al. Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder titration trial. J Child Adolesc Psychopharmacol. 2003;13:123-136
25. Galanter CA, Pagar DL, Davis M, et al. ADHD and manic symptoms: Diagnostic and treatment implications. Clinical Neuroscience Research. 2005;5:283-294
26. Arnold LE, Abikoff HB, Cantwell DP, et al. NIMH collaborative multimodal treatment study of children with ADHD (MTA): design, methodology, and protocol evolution. J Atten Disord. 1997;2:141-158
27. Arnold LE, Abikoff HB, Cantwell DP, et al. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry. 1997;54:865-870
28. Hinshaw S, March JS, Abikoff H, et al. Comprehensive assessment of childhood attention-deficit hyperactivity disorder in the context of a multisite, multimodal clinical trial. J Atten Disord. 1997;1:217-234
29. Swanson JM. School-Based Assessments and Interventions for ADD Students. Irvine, CA: KC Publications; 1992
30. Stringaris A, Goodman R. Mood lability and psychopathology in youth. Psychol Med. 2009;39:1237-1245
31. Loeber R, Green SM, Lahey BB. Mental-health professionals perception of the utility of children, mothers, and teachers as informants on childhood psychopathology. J Clin Child Psychol. 1990;19:136-143
32. Phares V. Accuracy of informants: do parents think that mother knows best? J Abnorm Child Psychol. 1997;25:165-171
33. Achenbach TM. Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Department of Psychiatry. Burlington, VT: University of Vermont; 1991
34. Bird HR, Shaffer D, Fisher P, et al. The Columbia Impairment Scale (CIS)-pilot findings on a measure of global impairment for children and adolescents. Int J Methods Psychiatr Res. 1993;3:167-176
35. Stringaris A, Goodman R. The value of measuring impact alongside symptoms in children in adolescents: a longitudinal assessment in a community sample. J Abnorm Child Psychol. 2013;41: 1109-1120
36. Rowe R, Costello EJ, Angold A, Copeland WE, Maughan B. Developmental pathways in oppositional defiant disorder and conduct disorder. J Abnorm Psychol. 2010;119:726-738
37. Krieger FV, Polanczyk VG, Robert G, et al. Dimensions of oppositionality in a Brazilian community sample: testing the DSM-5 proposal and etiological links. J Am Acad Child Adolesc Psychiatry. 2013;52: 389-400. e381
38. Kolko DJ, Pardini DA. ODD dimensions, ADHD, and callousunemotional traits as predictors of treatment response in children with disruptive behavior disorders. J Abnorm Psychol. 2010;119:713-725
39. Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748-751
40. Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001; 22:60-73
41. Blader JC, Schooler NR, Jensen PS, et al. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy. Am J Psychiatry. 2009;166:1392-1401
42. The MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder. Arch Gen Psychiatry. 1999;56:1088-1096
43. Landau S, Stahl D. Sample size and power calculations for medical studies by simulation when closed form expressions are not available. Stat Methods Med Res. 2013;22:324-345
44. Lenth RV. Post Hoc Power: Tables and Commentary. Iowa City: Department of Statistics and Actuarial Science, University of Iowa; 2007
45. Maughan B, Collishaw S, Stringaris A. Depression in childhood and adolescence. J Can Acad Child Adolesc Psychiatry. 2013; 22:35-40.